Home › Research › Topics › blood
blood
10 studies tagged blood, dated 2013-06-25 to 2026-01-05. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology 2026-01-05
- Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice 2024-08-03
- Mitochondrial DNA abundance in blood is associated with Alzheimer's disease- and dementia-risk 2024-07-15
Studies
10 studies carry this tag.
Date range
2013 to 2026
Top journals
- Alzheimer's & dementia (Amsterdam, Netherlands) 1
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Alzheimer's research & therapy 1
- Frontiers in aging neuroscience 1
- Journal of Alzheimer's disease : JAD 1
10 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Blood biomarkers have emerged as accurate tools for detecting Alzheimer's disease (AD) pathology, offering a minimally invasive alternative to traditional diagnostic methods such as imaging and cerebrospinal fluid (CSF) analysis.
-
Our multimarker blood test interpretation tool is ready for testing in real-world clinical dementia settings.
-
69/100
The mitochondrial cascade hypothesis of Alzheimer's disease (AD) has been portrayed through molecular, cellular, and animal studies; however large epidemiological studies are lacking.
-
We also explored economic viability of using two different plasma amyloid assays for pre-screening in AD prevention trials and as routine clinical diagnostic tool, versus amyloid PET alone.
-
Alzheimer's disease (AD) is increasingly prevalent worldwide, and disease-modifying treatments may soon be at hand; hence, now, more than ever, there is a need to develop techniques that allow earlier and more secure diagnosis.
-
In our study, in addition to PD, NFL was suggested to be a global diagnostic biomarker for neurodegenerative diseases.
-
These data suggest that apoJ may have potential in the context of use (COU) of AD diagnostics, I-309 may be specifically useful in the COU of identifying individuals at greatest risk for progressing toward AD.
-
The Aβ-40 and tau levels were higher and the Aβ-42 level and Aβ-42/Aβ-40 ratio were lower in DS than in the controls (all p < 0.001).
-
Alzheimer's disease (AD) is the primary cause of dementia in the elderly.
-
Advances in the field of blood biomarker discovery will help in identifying Alzheimer's disease in its preclinical stage, allowing treatment to be initiated before irreversible damage occurs.